Of note, RCC2 expression was not different between patients who did and did not receive adjuvant chemotherapy for stage III CRC in the two Norwegian series (online supplemental table 4), or between the two adjuvant treatment groups in QUASAR2 (online supplemental table 5). The gene discussed is RCC2; the disease is colorectal carcinoma.